Kuros Biosciences AG (KURN.SW)
Kuros Biosciences AG engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
23.20-0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago-22.8%
The outlook
Kuros Biosciences AG currently reads as leaning bullish based on strong buy — 1.3 avg of 4 analysts, mixed vs its moving averages, 33% of the way from its 52-week low to high, avg target +46% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.3 avg of 4 analysts
Price trendMixed vs its moving averages
52-week range33% of the way from its 52-week low to high
Price targetAvg target +46% vs current price
Analyst price target
~12-month · 4 analysts33.97average target+46.4% vs now
Now 23.20
Low 32.00High 38.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$915.0M
52-wk high
34.20
52-wk low
17.69
50-day avg
20.17
200-day avg
24.61
Trailing P/E
386.7